Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
(Approval lapsed) Bupivacaine Injection BP, bupivacaine hydrochloride 0.5% (100mg/20mL) single use vials
Section 19A approved medicine
(Approval lapsed) Bupivacaine Injection BP, bupivacaine hydrochloride 0.5% (100mg/20mL) single use vials
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
MARCAIN 0.5%w/v bupivacaine hydrochloride (as monohydrate) 100mg/20 mL injection ampoule - ARTG 48328
Indication(s)
Adults (> 18 years of age):
BUPIVACAINE INJECTION BP (bupivacaine hydrochloride) is indicated for:
- Local infiltration
- Peripheral minor or major nerve blocks
- Epidural block for surgery
- Epidural block by continuous infusion or intermittent bolus for postoperative or labour pain relief
Standard procedures for local infiltration, minor and major nerve blocks, retrobulbar block or epidural block should be observed.
Geriatrics (> 65 years of age):
Elderly patients should be given reduced doses commensurate with their age and physical condition.
Pediatrics (< 2 years of age):
Until further experience is gained in children younger than two years, administration of any presentation of bupivacaine injection in this age group is not recommended.